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Objectives: Drug dependence as a chronic disorder is reversible over time and
has a cost burden for individuals, families, and society. An individual who has
stopped taking drugs for a long time may start taking drugs again. The variables
affecting the reuse of drugs are not well known. Therefore a study of the factors
that increase the length of time away from drugs is essential.
Methods: This study used data collected by the Bushehr addiction treatment cen-
ters (Tolloe and Pasargadae) from 100 men with drug addiction from March 2006 to
September 2010. The shared frailty model was used to study the influence of vari-
ables on the duration of time away from drug use. The most common method for
entering intra-class (personal) correlation is the survival frailty model, which uses
parametric survival data for the evaluation of recurrent events. A Weibull distri-
bution for time to event with gamma shared frailty was used.
Results: The mean (standard deviation) age and age at onset of opium use of the
sample were 33.85 (8.11) and 20.65 (6.87), respectively. About 30% of the men
studied had chronic disease and 36% had a mental illness. The mean (frequency
mean) of the amount of opium used were 4.73 (3.8) g and 2.54 (1.14) times per
day. The desire to end drug use was 97% and 3% for the men with drug addiction
and their families, respectively, at the time when the men stopped using opium.
The age at onset of opium use [p Z 0.046, hazards ratio (HR)Z 1.30], history of
chronic disease (p Z 0.005, HR Z 249.635), and marital status (p Z 0.06,
HR Z 0.027) are important in the reuse of opium.
Conclusion: We found that opium addiction is related to other chronic diseases
and to the age at onset of opium use. A prospective study following up individuals
with drug addiction who try to stop drug use in addiction treatment centers could
help to determine the risk factors of resuming drug use.ted under the terms of the Creative Commons Attribution Non-Commercial License (http://
) which permits unrestricted non-commercial use, distribution, and reproduction in any
operly cited.
ase Control and Prevention. Published by Elsevier Korea LLC. All rights reserved.
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Drug dependence is a known social disorder and has
become a major problem in some communities in recent
years. Drug dependence causes long-term and recurrent
suffering for individuals, families, and communities and
a cure has not yet been found. Although an individual
may stop using drugs for a long time, he or she may
begin to use drugs again. Demographic and social fac-
tors and familial influence affect the start of drug use,
continuing drug use, and return to drug use after time
away from drugs [1]. During the addiction review pro-
cess there is a fundamental problem in that individuals
often have several unsuccessful attempts to stop drug
use prior to when they are successful in finally stopping
taking drugs [2]. It is therefore necessary to determine
the factors which can prolong the period away from
drugs.
The addiction process can thus be seen as a recurrent
event. Recurrent events data have often been analyzed
using standard survival analysis methods with an
adjustment for events occurring for each person that
leads to a marginal model or a frailty model [3].
As a result of the increasing use of survival analysis
in medical research, there is now a need for a more
flexible and efficient model for survival data. Standard
methods of survival analysis in clinical research are
based on the assumption that the sample is a homoge-
neous group. Thus survival models assume that the
survival of individual patients is independent of each
other and the patients’ survival time distributions are
the same. However, in many instances the study group
cannot be assumed to be homogeneous and individual
group members have different risk factors [4e6]. In
many instances the importance of some factors asso-
ciated with the disease are still unknown, e.g., eco-
nomic factors. It is very difficult or impossible to
measure all the effective and appropriate factors related
to an event [7]. Ignoring unknown shared risk factors
may lead to dependency between survival times and
bias estimation of parameters. In these situations, we
use frailty models to solve these problems. Frailty
models are the most common methods for entering the
intra-class (personal) correlation in survival analysis.
These models formulate the variation of survival times
as two sources. The first source is the natural variation
explained by hazard function and the second source is
the shared variation between individuals in a group
(individual) expressed by the shared frailty variable
[5,8,9].
There have been many studies on cigarette smoking
and its prevalence in Iran [10,11], but few studies about
ending drug and cigarette addiction. Li et al [12] used a
cure fraction frailty model to study smoking cessation.
Multiple regression using proportional hazards frailty
models was applied to identify independent predictorsand correlates of the duration of repeated abstinence
episodes [13]. It is important to know the risk factors
affecting the recurrence times of drug addicts who
attempt toend their use of drugs. In this study we used
the frailty model to determine these risk factors. We
used a gamma distribution with finite mean because the
risk function is always positive for the frailty. We also
used the frailty model to consider the heterogeneity in
individuals with drug addiction and we considered the
mean of the frailty variable to be equal to one [8,9].
2. Materials and methods
This study used data collected from 100 patients
admitted to two addiction treatment centers in Bushehr
(Tolloe and Pasargadae). The data were recorded from
March 2006 to September 2010. The available cova-
riates, demographic information, and drug use data were
collected. The time frame of this study was divided into
3 month intervals. Smoking status was defined by
questions about the use or non-use of drugs at 3 month
intervals.
Participants were allowed to indicate that during the
previous 3 months: (1) they had not used drugs at all; (2)
they had used drugs, but had stopped at some time
during the interval; or (3) they had used drugs contin-
uously. For the individuals who indicated (2), the time
of stopping drug use and the duration of cessation were
unknown. It is difficult to distinguish between groups (2)
and (3) and we considered them as “users since last
visit.” Individuals who answered (1) positively were
treated as non-users since their last visit.
In this study we only considered use of opium and
non-use of opium; use of other drugs was not consid-
ered. In addition to demographic questions and ques-
tions about employment status, three questions were
asked about the age of onset of the use of opium, the
history of chronic disease, and mental and psychiatric
illnesses. The following questions were also asked at
each 3 month time interval: (1) amount of opium used
and frequency of opium use per day; (2) the use or
non-use of other drugs (including heroin, crack
cocaine) at least once a week; (3) whether the decision
to stop drug use was made by the individual or with
their family; and (4) whether alcohol was consumed at
least once a week.
We used a parametric shared frailty analysis for
recurrent events. This included proportional hazards, a
Weibull distribution for time events, and gamma shared
frailty frequency dependence on time. We defined a
model based on the hazard of the kth individual in the jth
event and the ak frailty for this individual. Frailty is the
multiplicative risk effect of the hazard function
½hðtxjkÞ. This assumed a gamma distribution with a
mean of 1 and variance q. Also, we assumed that hðtxjkÞ
had a Weibull distribution. Therefore:
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where x1, x2 are covariates.
The frailty is included in the model to account for
unobserved participant-specific factors that are unac-
counted for by the other predictors in the model. These
unobserved participant-specific factors can be a source of
within-participant correlation. We used the shared frailty
term to indicate that observations of each individual are
clustered and correlated [13]. To fit the model, we
considered recurrence in each 3-month interval so that the
first interval of interest for every individual was the first
non-smoking interval. The continuously and repeated
non-use intervals were assumed to be a without recurrent
interval and the interval after these intervals in which the
individual reused narcotic drugs was assumed to be a
recurrent interval. Individuals who had made no attempt
to stop drug use were therefore left out of the study.
The opium consumption rate, consumption frequency,
employment status, and use of other drugs in each interval
were also recorded. For example, Figure 1 clearly shows
the narcotic-using status at each interval of one individ-
ual. The letters U and N denote opium use and non-use
intervals, respectively. An attempt to stop using opium
is defined as the opium non-use interval immediately after
a use interval (e.g., the first and fourth non-use intervals in
Figure 1). Similarly, a relapse to use is defined as the
opium use interval immediately after a non-use interval
(e.g., the second interval in Figure 1). For example, if an
individual follows an opium use pattern like that in
Figure 1, at the second period she or he has reused opium
and after two periods has attempted to stop opium use and
then relapsed to opium use in the sixth period. After 6
months again he or she has another attempt to stop drug
use and remains a non-user until the end of the study. The
variables in the model were selected using a forward
strategy with entry and removal of the 0.05 and 0.1 levels.
943. Results
All of the 100 individuals with a drug addiction in
this study were men. The mean (standard deviation)N NU NNUNNUUN
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Figure 1. Time plot of an indiviage and age at onset of drug use of the sample were
33.85 (8.11) and 20.65 (6.87), respectively. A total of
9.1% of the sample group were unemployed. About
30% of the sample had chronic disease and 36% had
a mental illness. Heroin and crack cocaine were used
by 25% of the sample. The mean amount of opium
used and its frequency mean were 4.73 (3.8) g and
2.54 (1.14) per day. A total of 10% of the sample
drank alcohol at least once a day. The decision to
stop drug use was made by the drug users in 97% of
the sample and by their family in 3% of the sample in
the intervals in which the individuals stopped using
opium.
Table 1 gives the results of the model with the shared
frailty component. For q Z 0, the likelihood ratio test
was statistically significant (p < 0.001) and suggested
within-participant correlation so the frailty component
must be in the model. The estimated Weibull shape
parameter p is 4.89 and indicates an increased hazard
over time (bp > 1). However, the Wald test shows
ln(p)Z 0 (pZ 1) is significant (p < 0.001).This means
the time to recurrence risk increases. The table also
shows that the age at the onset of addiction [pZ 0.046,
hazard ratio (HR) Z 1.30], history of chronic disease
(p Z 0.005, HR Z 249.635), and marital status
(p Z 0.06, HR Z 0.027) have a significant role in the
relapse time to using opium again.4. Discussion
To address the factors affecting the cessation of drug
use in the field of treatment for drug addiction, this study
followed up behavioral outcomes at various time in-
tervals. The parameters measured were analyzed in a
traditional frailty model to determine the factors which
affect the reuse of opium [3e5]. We recommend col-
lecting these measures during the course of treatment;
however, in this work we used historical data registered
with addiction treatment centers.
In a previous study, factors such as inappropriate
friends, unemployment, poverty, family problems,
improper behavior of family, and improper behavior of
spouses were found to be related to a return to drug
abuse [14]. In study conducted by Seraji et al [15], the
factors affecting a relapse to drug use were found to be
unemployment and changes in income. However, in this
study we found that the age at onset of drug use and a
history of chronic disease were both significant in the
time interval to a return to drug use. Marital status was
also significant to relapse time at the 0.1 level.End of studyN NNNNNN
  12   13   14    15   16    17   18
dual’s pattern of using opium.
Table 1. Parametric model with frailty component
Parameter Coefficient SE p
95% Confidence interval
Upper band Lower band
Age at onset of addiction (y) 0.26 0.13 0.047 0.003 0.52
Marital status (yes Z 1, no Z 0) 3.62 1.97 0.060 7.47 0.23
History of chronic disease (yes Z 0, no Z 1) 5.52 1.99 0.005 1.63 9.42
Intercept 9.2 3.64 0.011 16.3 2.07
Ln(p) 1.59 0.3 0.000 1.00 2.19
Ln(q) 0.61 0.37 0.090 0.11 1.33
P (Weibul shape parameter) 4.93 1.49 2.72 8.92
1/p 0.2 0.06 0.11 0.37
q (frailty variance) 1.84 0.67 0.89 3.78
Likelihood ratio test for q Z 0: x2 Z 23.09 and p < 0.001. SE Z standard error.
Drug abuse relapse event rate over time 95Some workers have considered addiction as a chronic
illness [16,17]. We found historically that having at least
one chronic disease affected the relapse time. In other
words, the addiction is related to other chronic diseases
such as mental disorders.
The potential limitations of this study include the
reliance on self-reported data. As the time elapsed since
the event of first opium use will be longer for those who
started at a younger age, the shift in age of first opium
use would probably be even more obvious. As we relied
on the self-reporting of interval times for opium use,
these times may not be completely true and may be
biased.
In conclusion, we found the addiction is related to
other chronic diseases and to the age at which drug
abuse began. Developing a prospective study to follow
up individuals with addiction who try to stop drug use in
addiction treatment centers could help to determine the
risk factors for resuming drug use.Conflicts of interest
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